Pharmacy Law Archives | Page 57 of 59 | Frier Levitt - Attorneys at Law
↓ Skip to Main Content

The Government has a fund to help COVID-19 victims’ families. Click here for more information.

Healthcare
Life Sciences & Pharmacy

Main Navigation

  • Home
  • About
    • About Us
    • Meet Our Attorneys
    • Our Staff
    • News & Press
  • What we do
    • Healthcare
      • Medical Practice Mergers & Supergroups
      • Telemedicine & Telehealth
      • Healthcare Practice Compliance
      • HIPAA Compliance
      • Hospital/Physician Negotiations and Joint Ventures
      • Healthcare Litigation
      • Medicare, Medicaid, and Other Commercial Payor Audits & Appeals
      • Out-of-Network Provider Issues
      • Medical Practice Representation
      • Pain Management Compliance
      • Professional Board Actions
      • In-house Counsel Legal Support Services
      • Administrative and Insurance Defense Law
      • Ambulatory Care Facility Formation & Representation
      • Antitrust
      • Data Transactions
      • Employment Matters
      • Federal and State Fraud and Abuse Counseling
      • Private Equity Investing
      • Managed Care Negotiations and Strategies
      • Physician Dispensing
      • Value Based Care
      • Clinical Trials / Human Subjects Research
      • White Collar Criminal Defense & Government Investigations
      • Intellectual Property Services
    • Life Sciences & Pharmacy
      • Defending Pharmacies in PBM Audits
      • DIR Fees
      • Payor Network Access and Defense of Network Terminations
      • MAC Pricing & Appeals
      • Medicare Audit Appeals
      • Plan Sponsor PBM Contract Services
      • Antitrust Tools Available to Combat PBM Abuse of Pharmacies
      • Telehealth & Telemedicine
      • 340B Covered Entity and Contract Pharmacy Regulatory and Contract Support
      • Intellectual Property Services
      • Review of Promotional and Advertising Materials
      • Physician Dispensing
      • Private Equity Investing in Specialty Pharmacy & Pharmaceutical Companies
      • White Collar Criminal Defense & Government Investigations
      • Value Based Care
      • Federal & State Fraud and Abuse Counseling
      • Employment Matters
      • Pharmacy Transactions
      • National Board of Pharmacy Matters
      • Risk Assessment Mitigation Strategy
      • Medicare Advantage Risk Adjustment Litigation
      • PBM Qui Tam Lawsuits
  • Who we serve
    • Healthcare
      • Physicians and All Types of Single and Multi-Specialty Practice Groups
      • Hospitals and Healthcare Systems
      • Clinically Integrated Networks
      • Ambulatory Care Facilities/Ambulatory Surgery Centers (ASCs)
      • Medical Spas and Cosmetic Services
      • Dental Practices
      • Laboratories
      • Skilled Nursing Facilities and Long-Term Care
      • Value Based Care Organizations: ACOs, IPAs and CINs
      • Urologists
    • Life Sciences & Pharmacy
      • Specialty Pharmacies
      • Community, Retail Pharmacies
      • Chain Pharmacies
      • Fertility Pharmacies
      • Long-Term Care Pharmacies
      • Supermarket Pharmacies
      • Compounding Pharmacies (503A)
      • Clinically Integrated Networks (“CINs”)
      • Home Infusion Providers
      • Integrated Delivery Network
      • Pharmaceutical Manufacturers
      • Pharmaceutical Wholesalers
      • Outsourcing Facilities (503B)
      • State & National Pharmacy Association
      • Veterinary Compounders
      • Biotechnology Companies
      • Urologists
  • Insights
    • Blogs & Articles
    • Videos
    • Download Tools
    • Upcoming Events
    • Recent Results
    • Webinars
    • COVID-19 Resources
  • Join our team
    • Careers
  • Contact
Frier Levitt – Attorneys at Law
Pharmacy Law
Home › Blogs & Articles › Service › Pharmacy Law › Page 57
Home › Blogs & Articles › Service › Archive for Pharmacy Law › Page 57

Category: Pharmacy Law

Recent Walgreens Settlement of False Claims Act Violations Highlights the Effectiveness of Qui Tam Actions

Jonathan E. Levitt, Esq. and Jesse C. Dresser, Esq. July 5, 2012
Late last month, the United States Department of Justice announced that Walgreens Pharmacy had agreed to pay $7.9 million to settle allegations that Walgreens had violated the Federal False Claims Act. In a suit brought as a qui tam action by a... Read More
Pharmacy Law

OIG Report on Test Strips and Lancets Forecasts Increased Auditing of Pharmacy/DME Suppliers

Jonathan E. Levitt, Esq. and Todd Mizeski, Esq. June 27, 2012
On June 13, 2012, the OIG issued a report following its review of four contractors that processed claims for test strips and/or lancets. The report concludes that the Medicare contractors improperly allowed for payment of a total of approximately... Read More
Pharmacy Law

With Regulatory Enforcement of HIPAA on the Rise and Increased Penalties for Non-Compliance, Pharmacies Must Take Action

John E. Morrone, Esq. June 8, 2012
The United States Department of Health and Human Services Office for Civil Rights (OCR) has stepped up enforcement of the compliance requirements contained in the Health Insurance Portability and Accountability Act of 1996 (HIPAA), and has begun... Read More
Pharmacy Law

OIG Advisory Opinion Related to Patient Copayment

Jonathan E. Levitt, Esq. and Jesse C. Dresser, Esq. June 7, 2012
The OIG recently issued an Advisory Opinion Letter to an anonymous pharmacy that relates to a hot-topic Pharmacy Law Issue—Copayment Assistance. The OIG advised that it would not take any action against the pharmacy for a “proposed... Read More
Pharmacy Law

Are PSAOs Looking Out for Your Pharmacy’s Best Interests? A Request for Pharmacy Feedback

Jonathan E. Levitt, Esq. and Todd Mizeski, Esq. May 14, 2012
A pharmacy owner recently lamented that she experienced a sudden and significant reduction in reimbursement rates for compounds dispensed to patients whose insurance coverage had not changed. The decrease in reimbursement began immediately after a... Read More
Pharmacy Law

Q&A Regarding Copay Reimbursement Programs

Jonathan E. Levitt, Esq. and Todd Mizeski, Esq. May 2, 2012
We see a significant “chatter” within our pharmacy client base regarding copay reimbursement programs. The legality of these programs and how the pharmacy may/should treat copay cards and/or coupons is at issue. The following Q & A is... Read More
Pharmacy Law

New Court Ruling Potentially Revives Independent Pharmacy Class Action Arbitration Against PBMs

Jonathan E. Levitt, Esq. and Todd Mizeski, Esq. April 25, 2012
Class Action is the most powerful tool in a lawyer’s arsenal to help independent pharmacies force national-scale changes in abusive PBM auditing conduct. In 2009, Frier Levitt obtained a $12+ Million class action arbitration award against one of... Read More
Pharmacy Law

The FTC approved the ESI-Medco Merger, Now What? A Call For Uniform State Laws Protecting Pharmacies (Any Willing Provider; Prompt Pay)

Jonathan E. Levitt, Esq. and Jesse C. Dresser, Esq. April 2, 2012
The Federal Trade Commission (FTC) approved the merger between Express Scripts, Inc. (ESI) and Medco Health Solutions, Inc. (Medco), two of the country’s three largest Pharmacy Benefit Managers (PBMs). What can pharmacies do to curb abusive PBM... Read More
Pharmacy Law

New Law Promotes Competition for Retail Pharmacies by Banning Mandatory Mail-Order Prescription Plans in New York

Jonathan E. Levitt, Esq. and Jesse C. Dresser, Esq. December 30, 2011
On December 12, 2011, New York Governor Andrew Cuomo signed a bill into law a bill which bans Pharmacy Benefit Managers (“PBMs”) from mandating customers to use mail order pharmacies for prescription drugs. Known as the New York AMMO Law, the... Read More
Pharmacy Law

Prevent Potential Liability to State and Federal Agencies for “Excluded Providers”

Jonathan E. Levitt, Esq. and Jesse C. Dresser, Esq. December 15, 2011
In September of this year, the New York Attorney General recoup nearly $250,000 in restitution to resolve a Medicaid fraud case involving the misdeeds of a former pharmacist for Tops Market Pharmacy, headquartered in Williamsville, New York. One of... Read More
Pharmacy Law

Posts navigation

Previous 1 … 55 56 57 58 59 Next

Search

Filter by Industry

Filter by Service

Contact





    Value Based Care insights

    COVID-19 Compensation for Victims- CICP ProgramFebruary 24, 2021

    Watch Video

    Videos

    How Will the Recently Promulgated CMS and OIG Final Rules Affect My Practice? – Part IDecember 21, 2020

    Read More

    Value Based Care | Articles

    Upcoming Events

    WHAT’S NEW FOR PHARMA IN 2021?March 4, 2021

    Learn More

    Events

      Let us help you find solutions.

      I'm interested in:
      Pharmacy LawHealthcare Law

      84 Bloomfield Avenue
      Pine Brook, NJ 07058
      973.618.1660

      101 Greenwich Street, Suite 8B
      New York, NY 10006
      646.970.2711

      626 RXR Plaza West Tower, 6th Floor
      Uniondale, NY 11556
      516.755.7916

        Sign up for our newsletter

        I'm interested in:
        Pharmacy LawHealthcare Law

        The contents of this website may contain attorney advertising under the laws of various states. Prior results do not guarantee a similar outcome.

        Terms of Use | Privacy Policy

        © 2021
        • Home
        • About
          • About Us
          • Meet Our Attorneys
          • Our Staff
          • News & Press
        • What we do
          • Healthcare
            • Medical Practice Mergers & Supergroups
            • Telemedicine & Telehealth
            • Healthcare Practice Compliance
            • HIPAA Compliance
            • Hospital/Physician Negotiations and Joint Ventures
            • Healthcare Litigation
            • Medicare, Medicaid, and Other Commercial Payor Audits & Appeals
            • Out-of-Network Provider Issues
            • Medical Practice Representation
            • Pain Management Compliance
            • Professional Board Actions
            • In-house Counsel Legal Support Services
            • Administrative and Insurance Defense Law
            • Ambulatory Care Facility Formation & Representation
            • Antitrust
            • Data Transactions
            • Employment Matters
            • Federal and State Fraud and Abuse Counseling
            • Private Equity Investing
            • Managed Care Negotiations and Strategies
            • Physician Dispensing
            • Value Based Care
            • Clinical Trials / Human Subjects Research
            • White Collar Criminal Defense & Government Investigations
            • Intellectual Property Services
          • Life Sciences & Pharmacy
            • Defending Pharmacies in PBM Audits
            • DIR Fees
            • Payor Network Access and Defense of Network Terminations
            • MAC Pricing & Appeals
            • Medicare Audit Appeals
            • Plan Sponsor PBM Contract Services
            • Antitrust Tools Available to Combat PBM Abuse of Pharmacies
            • Telehealth & Telemedicine
            • 340B Covered Entity and Contract Pharmacy Regulatory and Contract Support
            • Intellectual Property Services
            • Review of Promotional and Advertising Materials
            • Physician Dispensing
            • Private Equity Investing in Specialty Pharmacy & Pharmaceutical Companies
            • White Collar Criminal Defense & Government Investigations
            • Value Based Care
            • Federal & State Fraud and Abuse Counseling
            • Employment Matters
            • Pharmacy Transactions
            • National Board of Pharmacy Matters
            • Risk Assessment Mitigation Strategy
            • Medicare Advantage Risk Adjustment Litigation
            • PBM Qui Tam Lawsuits
        • Who we serve
          • Healthcare
            • Physicians and All Types of Single and Multi-Specialty Practice Groups
            • Hospitals and Healthcare Systems
            • Clinically Integrated Networks
            • Ambulatory Care Facilities/Ambulatory Surgery Centers (ASCs)
            • Medical Spas and Cosmetic Services
            • Dental Practices
            • Laboratories
            • Skilled Nursing Facilities and Long-Term Care
            • Value Based Care Organizations: ACOs, IPAs and CINs
            • Urologists
          • Life Sciences & Pharmacy
            • Specialty Pharmacies
            • Community, Retail Pharmacies
            • Chain Pharmacies
            • Fertility Pharmacies
            • Long-Term Care Pharmacies
            • Supermarket Pharmacies
            • Compounding Pharmacies (503A)
            • Clinically Integrated Networks (“CINs”)
            • Home Infusion Providers
            • Integrated Delivery Network
            • Pharmaceutical Manufacturers
            • Pharmaceutical Wholesalers
            • Outsourcing Facilities (503B)
            • State & National Pharmacy Association
            • Veterinary Compounders
            • Biotechnology Companies
            • Urologists
        • Insights
          • Blogs & Articles
          • Videos
          • Download Tools
          • Upcoming Events
          • Recent Results
          • Webinars
          • COVID-19 Resources
        • Join our team
          • Careers
        • Contact